Markets
Will NASA officially confirm the honeycomb-like patterns on Mars are of biological origin by August 31, 2026?
Yes0%No0%
Loading...
About this market
This market resolves to Yes if NASA publicly announces or confirms, through an official communication, press release, or peer-reviewed study, that the recently discovered honeycomb-like patterns on Mars are of biological origin (e.g., linked to past microbial or organic life) by August 31, 2026. If no such confirmation is made or if NASA confirms the patterns are of non-biological origin by this date, the market resolves to No.
Rules
- Market closes at 8/31/2026.
- Logic weighted resolution applies.
Other open markets in Science
Will the NSF reverse its recent grant reduction decision by the end of 2026?
This market resolves to Yes if the National Science Foundation (NSF) announces a reversal of its decision to award roughly 46% fewer research grants compared to the 2021–24 average, with an increase in grant distribution announced by December 31, 2026.
Will the octopus release experiment lead to a noticeable reduction in invasive blue crab population by December 31, 2026?
This market resolves to Yes if official reports by December 31, 2026, show a substantial reduction in the invasive blue crab population due to the octopus release experiment off Italy's Adriatic coast.
Will the TOFA compound enter human clinical trials for obesity treatment by December 31, 2027?
This market resolves to Yes if the molecular compound 5-tetradecyloxy-2-furoic acid (TOFA) begins human clinical trials focused on obesity treatment by December 31, 2027. TOFA has shown promising results in mice for increasing energy usage and reducing body fat. The resolution will be based on official announcements from scientific institutions or pharmaceutical companies.
Will NASA identify a new application of GeoCryoAI by February 1, 2027?
This market resolves to Yes if NASA publicly announces a new application of its GeoCryoAI framework, beyond mapping zero-curtain conditions, by February 1, 2027.
Will AI-designed intrabodies be used in clinical trials for Alzheimer's, Parkinson's, or MND by December 31, 2027?
This market resolves to Yes if any AI-designed intrabodies are used in clinical trials for Alzheimer's, Parkinson's, or Motor Neurone Disease by December 31, 2027. To confirm resolution, announcements from reputable research institutions or clinical trial registries will be used.
Will the concept of 'disruptive science' undergo a significant revision in a major scientific journal by December 2027?
This market resolves to Yes if a major scientific journal such as Nature, Science, or Cell publishes an article by December 2027 that significantly revises the understanding of 'disruptive science' in light of new methodologies or data corrections. The article must have a clear impact on the field, as evidenced by significant citations or coverage in science policy discussions.